Moderated by Precision's Ross Maclean, our distinguished panel of experts provide key insights on why social determinants of health (SDOH) are critical factors to inform today's treatment planning, care delivery, health policy, health outcomes and value.
Precision's Jason Shafrin identifies three key trends to consider when assessing the value of new innovations for 2021.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
